Bio-Rad Laboratories: Overview of Second Quarter Results

Bio-Rad Laboratories BIO released its second quarter results on Thursday, July 28, 2022 at 4:00 p.m.

Here's what investors need to know about the announcement.

Earnings

Bio-Rad Laboratories exceeded its estimated earnings by 20.71%, recording EPS of $3.38 versus an estimate of $2.8.

Revenue decreased by $24.83 million compared to the same period last year.

Past Earnings Performance

Last quarter, the company beat EPS by $1.54, followed by a 0.2% decline in share price the next day.

Here is an overview of Bio-Rad Laboratories past performance:

Trimester Q1 2022 Q4 2021 Q3 2021 Q2 2021 EPS estimate 3.40 2.85 2.44 2.66 Actual EPS 4.94 3.21 3.71 3.54 Revenue estimate 675.10M 731.98M 661.87M 631.78M Actual turnover 700.06M 732.77M 715.20M 715.93M

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021 EPS estimate 3.40 2.85 2.44 2.66 Actual EPS 4.94 3.21 3.71 3.54 Revenue estimate 675.10M 731.98M 661.87M 631.78M Actual turnover 700.06M 732.77M 715.20M 715.93M

To follow all earnings releases for Bio-Rad Laboratories, visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.